ETON - Eton Pharmaceuticals, Inc.

QQQ $ 629.78 $ -3.11 (-0.49 %)

DIA $ 472.70 $ -2.66 (-0.56 %)

SPY $ 681.88 $ -2.29 (-0.33 %)

TLT $ 89.68 $ 0.07 (0.08 %)

GLD $ 366.72 $ 0.05 (0.01 %)

Previous Close

$ 17.96

Open

$ 18.00

Bid

$ 17.40 x 200

Ask

$ 19.78 x 102

Day's Range

$ 17.49 - $ 18.22

52 Week Range

$ 8.24 - $ 23.00

Volume

312,589

Average Volume

Market Cap

481.64M

Beta (5Y Monthly)

$ 1.02

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	08-07-2025	06-30-2025	10-Q
2	05-13-2025	03-31-2025	10-Q
3	03-18-2025	12-31-2024	10-K
4	11-12-2024	09-30-2024	10-Q
5	08-08-2024	06-30-2024	10-Q
6	05-09-2024	03-31-2024	10-Q
7	03-14-2024	12-31-2023	10-K
8	11-09-2023	09-30-2023	10-Q
9	08-10-2023	06-30-2023	10-Q
10	05-11-2023	03-31-2023	10-Q
11	03-16-2023	12-31-2022	10-K
12	11-10-2022	09-30-2022	10-Q
13	08-11-2022	06-30-2022	10-Q
14	05-12-2022	03-31-2022	10-Q
15	03-16-2022	12-31-2021	10-K
16	11-16-2021	09-30-2021	10-Q
17	08-16-2021	06-30-2021	10-Q
18	05-13-2021	03-31-2021	10-Q
19	03-16-2021	12-31-2020	10-K
20	11-12-2020	09-30-2020	10-Q
21	08-12-2020	06-30-2020	10-Q
22	05-14-2020	03-31-2020	10-Q
23	03-05-2020	12-31-2019	10-K
24	11-14-2019	09-30-2019	10-Q
25	08-06-2019	06-30-2019	10-Q
26	05-07-2019	03-31-2019	10-Q
27	03-25-2019	12-31-2018	10-K
28	12-20-2018	09-30-2018	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

Eton Pharmaceuticals Q2 Adj. EPS $(0.10) M...
08/07/2025 20:06:08

Eton Pharmaceuticals (NASDAQ:ETON) reported quarterly losses of $(0.10) per share which missed the analyst consensus estimate o...

Earnings Scheduled For August 7, 2025
08/07/2025 08:33:15

The FDA Has Accepted Eton Pharmaceuticals'...
07/08/2025 10:52:49

ET-600 is a proprietary formulation of desmopressin oral solution developed for the treatment of central diabetes insipidius, a...

Eton Pharmaceuticals To Join Russell 2000 ...
06/27/2025 10:51:23

fda-approves-eton-pharmas-oral-drug-for-adrenal-insufficiency-in-pediatric-patients-analyst-sees-boost-in-2025-revenue

FDA Approves Eton Pharma's Oral Drug For A...
05/29/2025 16:42:18

Eton Pharma's Khindivi has won FDA approval as a pediatric adrenal insufficiency treatment. It is projected to surge in sal...

HC Wainwright & Co. Maintains Buy on Eton ...
05/29/2025 11:12:07

HC Wainwright & Co. analyst Swayampakula Ramakanth maintains Eton Pharmaceuticals (NASDAQ:ETON) with a Buy and raises th...

Eton Pharmaceuticals Receives U.S. FDA App...
05/28/2025 21:29:54

B. Riley Securities Reiterates Buy on Eton...
05/16/2025 17:17:14

B. Riley Securities analyst Madison El-Saadi reiterates Eton Pharmaceuticals (NASDAQ:ETON) with a Buy and raises the price t...

A Glimpse Into The Expert Outlook On Eton ...
05/14/2025 18:01:09

Craig-Hallum Maintains Buy on Eton Pharmac...
05/14/2025 17:43:40

Craig-Hallum analyst Chase Knickerbocker maintains Eton Pharmaceuticals (NASDAQ:ETON) with a Buy and raises the price target...

Eton Pharmaceuticals Q1 Adj. EPS $0.07 Bea...
05/13/2025 20:05:31

Eton Pharmaceuticals (NASDAQ:ETON) reported quarterly earnings of $0.07 per share which beat the analyst consensus estimate of ...

Earnings Scheduled For May 13, 2025
05/13/2025 08:32:43

A Look Ahead: Eton Pharmaceuticals's Earni...
05/12/2025 14:03:13

Eton Pharma Submits NDA To FDA For Proprie...
04/28/2025 10:53:41

- NDA submitted for the treatment of central diabetes insipidus -- Expected 10-month review; commercial preparations underway f...

Eton Pharmaceuticals Out-Incenses Commerci...
04/01/2025 11:07:26

Craig-Hallum Maintains Buy on Eton Pharmac...
03/19/2025 16:16:04

Craig-Hallum analyst Chase Knickerbocker maintains Eton Pharmaceuticals (NASDAQ:ETON) with a Buy and raises the price target...

B. Riley Securities Reiterates Buy on Eton...
03/19/2025 15:49:02

B. Riley Securities analyst Madison El-Saadi reiterates Eton Pharmaceuticals (NASDAQ:ETON) with a Buy and raises the price t...

5 Analysts Assess Eton Pharmaceuticals: Wh...
03/19/2025 13:00:59

HC Wainwright & Co. Reiterates Buy on Eton...
03/19/2025 10:29:02

HC Wainwright & Co. analyst Swayampakula Ramakanth reiterates Eton Pharmaceuticals (NASDAQ:ETON) with a Buy and maintain...

Eton Pharmaceuticals Q4 2024 GAAP EPS $(0....
03/18/2025 10:51:53